Literature DB >> 2223378

The influence of age on N-isopropyl-p-[123I]iodoamphetamine accumulation in the human heart.

M Nakajo1, Y Nakabeppu, S Iwashita, S Shinohara.   

Abstract

Variations in heart intensity in the 30 min and 4 hr chest images of the radiolabelled lipophilic amine, N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) were observed in 130 patients with lung diseases, aged 23 to 85 yrs. The heart intensity had a significant positive linear correlation with age (r = 0.43 at 30 min, 0.66 at 4 hr). The ratio of 4 hr heart intensity to 30 min heart intensity also had a positive linear correlation (r = 0.59), suggesting slower clearance of the radioactivity from the heart in older than in younger patients during this interval. Other parameters including sex, EKG findings, liver function, blood pressure, the presence of diabetes mellitus and smoking history had no relationship to heart intensity. A significant difference between heart intensities in bronchogenic carcinoma and pneumonia patient groups might be probably due to the age difference between the two groups. Therefore heart intensity in the 4 hr 123I-IMP image may reflect certain metabolic and/or myocardial change(s) with aging.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223378     DOI: 10.1007/bf03164595

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  18 in total

1.  Quantification of melanin in hepatic and cardiac lipofuscin.

Authors:  L M Ambani; J W Jhung; L M Edelstein; M H Van Woert
Journal:  Experientia       Date:  1977-03-15

2.  [Serial lung imaging with 123I-IMP in localized pulmonary lesions].

Authors:  M Nakajo; J Shimada; M Shimozono; N Uchiyama; Y Hiraki; S Shinohara
Journal:  Kaku Igaku       Date:  1988-05

3.  Biodistribution and dosimetry of N-isopropyl-p-[123I]iodoamphetamine in the primate.

Authors:  B L Holman; R E Zimmerman; J R Schapiro; M L Kaplan; A G Jones; T C Hill
Journal:  J Nucl Med       Date:  1983-10       Impact factor: 10.057

4.  Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl I-123 p-iodoamphetamine: concise communication.

Authors:  T C Hill; B L Holman; R Lovett; D H O'Leary; D Front; P Magistretti; R E Zimmerman; S Moore; M E Clouse; J L Wu; T H Lin; R M Baldwin
Journal:  J Nucl Med       Date:  1982-03       Impact factor: 10.057

5.  A noninvasive procedure for in vivo assay of a lung amine endothelial receptor.

Authors:  J J Touya; J Rahimian; D E Grubbs; H F Corbus; L R Bennett
Journal:  J Nucl Med       Date:  1985-11       Impact factor: 10.057

6.  Effect of antidepressant and narcoleptic drugs on N-isopropyl p-iodoamphetamine biodistribution in animals.

Authors:  J L Moretti; B L Holman; L Delmon; A Carmel; D Johnson; P Moingeon; M Blau
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

7.  Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique.

Authors:  J Rahimian; E C Glass; J J Touya; S F Akber; L S Graham; L R Bennett
Journal:  J Nucl Med       Date:  1984-01       Impact factor: 10.057

8.  Comparison of N-isopropyl (I-123) p-iodoamphetamine brain scans using Anger camera scintigraphy and single-photon emission tomography.

Authors:  R G Lee; T C Hill; B L Holman; R Uren; M E Clouse
Journal:  Radiology       Date:  1982-12       Impact factor: 11.105

Review 9.  Cardiac drugs: adjusting their use in aging patients.

Authors:  J B Schwartz; D R Abernethy
Journal:  Geriatrics       Date:  1987-08

10.  Regional quantitative noninvasive assessment of cerebral perfusion and function with N-isopropyl-[123I]p-iodoamphetamine.

Authors:  G K von Schulthess; E Ketz; P A Schubiger; A Bekier
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.